The role of bioinformatics in studying rheumatic and autoimmune disorders

Nature Reviews Rheumatology

Volumn 7, Issue 8, 2011, Pages 489-494

  Sirota, Marina ^a   Butte, Atul J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; HEAT SHOCK PROTEIN 90 INHIBITOR; HISTONE DEACETYLASE INHIBITOR; NOTCH4 RECEPTOR; PROTEIN BTNL2; PROTEIN CDSN; PROTEIN TAP2; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; BIOINFORMATICS; DISEASE CLASSIFICATION; DRUG RESEARCH; DRUG TARGETING; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MATHEMATICAL COMPUTING; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSLATIONAL RESEARCH;

AUTOIMMUNE DISEASES; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; HUMANS; RHEUMATIC DISEASES; SYSTEMS BIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80051468839     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.87     Document Type: Review

References (40)

1. Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002). (Pubitemid 34679544)
2. Barrett, T. et al. NCBI GEO: Archive for high-Throughput functional genomic data. Nucleic Acids Res. 37, D885-D890 (2009).
3. Butte, A. J. Translational bioinformatics applications in genome medicine. Genome Med. 1, 64 (2009).
4. Walsh, N. C., Crotti, T. N., Goldring, S. R. & Gravallese, E. M. Rheumatic diseases: The effects of inflammation on bone. Immunol. Rev. 208, 228-251 (2005). (Pubitemid 41746396)
5. Coward, J., Germain, R. N. & Altan-Bonnet, G. Perspectives for computer modeling in the study of T cell activation. Cold Spring Harb. Perspect. Biol. 2, a005538 (2010).
6. Germain, R. N. Computational analysis of T cell receptor signaling and ligand discrimination-past, present, and future. FEBS Lett. 584, 4814-4822 (2010).
7. Crow, M. K. & Wohlgemuth, J. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 5, 279-287 (2003). (Pubitemid 37407977)
8. Han, G. M. et al. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 4, 177-186 (2003).
9. Booth, G. et al. Gene expression profiles at different stages of collagen-induced arthritis. Autoimmunity 41, 512-521 (2008).
10. Raychaudhuri, S. et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41, 1313-1318 (2009).
11. Ptacek, T., Li, X., Kelley, J. M. & Edberg, J. C. Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet. Genome Res. 123, 142-147 (2008).
12. Graham, R. R., Hom, G., Ortmann, W. & Behrens, T. W. Review of recent genome-wide association scans in lupus. J. Intern. Med. 265, 680-688 (2009).
13. Freudenberg, J. et al. Locus category based analysis of a large genome-wide association study of rheumatoid arthritis. Hum. Mol. Genet. 19, 3863-3872 (2010).
14. Stahl, E. A. et al. Genome-wide association study meta-Analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514 (2010).
15. Tsuchiya, N., Ito, I. & Kawasaki, A. Association of IRF5, STAT4 and BLK with systemic lupus erythematosus and other rheumatic diseases. Nihon Rinsho Meneki Gakkai Kaishi 33, 57-65 (2010).
16. Mackay, I. R. Clustering and commonalities among autoimmune diseases. J. Autoimmun. 33, 170-177 (2009).
17. Orozco, G. et al. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum. Immunol. 66, 1235-1241 (2005).
18. Wang, K. et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum. Mol. Genet. 19, 2059-2067 (2010).
19. Huang, W., Wang, P., Liu, Z. & Zhang, L. Identifying disease associations via genome-wide association studies. BMC Bioinformatics 10 (Suppl. 1), S68 (2009).
20. Torkamani, A., Topol, E. J. & Schork, N. J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92, 265-272 (2008).
21. Sirota, M., Schaub, M. A., Batzoglou, S., Robinson, W. H. & Butte, A. J. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet. 5, e1000792 (2009).
22. Dudley, J. T., Tibshirani, R., Deshpande, T. & Butte, A. J. Disease signatures are robust across tissues and experiments. Mol. Syst. Biol. 5, 307 (2009).
23. Ungethuem, U. et al. Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol. Genomics 42A, 267-282 (2010).
24. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus. Immunity 29, 150-164 (2008). (Pubitemid 351952461)
25. Lamb, J. et al. The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935 (2006). (Pubitemid 44497995)
26. Iskar, M. et al. Drug-induced regulation of target expression. PLoS Comput. Biol. 6, e1000925 (2010).
27. Iorio, F. et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl Acad. Sci. USA 107, 14621-14626 (2010).
28. Garman, K. S. et al. A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proc. Natl Acad. Sci. USA 105, 19432-19437 (2008).
29. Setlur, S. R. et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J. Natl Cancer Inst. 100, 815-825 (2008). (Pubitemid 351809667)
30. Pujol, A., Mosca, R., Farrés, J. & Aloy, P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol. Sci. 31, 115-123 (2010).
31. Zhong, H., Yang, X., Kaplan, L. M., Molony, C. & Schadt, E. E. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am. J. Hum. Genet. 86, 581-591 (2010).
32. Chen, R. et al. FitSNPs: Highly differentially expressed genes are more likely to have variants associated with disease. Genome Biol. 9, R170 (2008).
33. Hsu, Y. H. et al. An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet. 6, e1000977 (2010).
34. Chen, D. P. et al. Clinical arrays of laboratory measures, or "clinarrays", built from an electronic health record enable disease subtyping by severity. AMIA Annu. Symp. Proc. 2007, 115-119 (2007).
35. Patel, C. J., Bhattacharya, J. & Butte, A. J. An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS ONE 5, e10746 (2010).
36. Utz, P. J. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 13, 304-311 (2004). (Pubitemid 38788487)
37. Hueber, W. et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52, 2645-2655 (2005). (Pubitemid 41369092)
38. Raychaudhuri, S. et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 40, 1216-1223 (2008).
39. Pointon, J. J. et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 11, 490-496 (2010).
40. Zhang, H. G. et al. Novel tumor necrosis factor a-regulated genes in rheumatoid arthritis. Arthritis Rheum. 50, 420-431 (2004).